With your help, we can care for our community in this time of need through any of top funding priorities outlined below.
Swedish is involved in two clinical trials using the drug Remdisivir, a promising broad-spectrum anti-viral currently being used to treat moderate-to-severeCOVID-19. With your support we can expand access to high-need individuals who are not subjects in those trials.
This oncological supportive care drug, which has been shown to stimulate and strengthen the immune system, may help patients recover from COVID-19 pneumonia. Thanks to our strong team of hematologists, we are well positioned to design and administer a trial to study its effectiveness.
Henry Kaplan, M.D., a revered Swedish physician and researcher is designing a clinical trial using hydroxychloroquine, an anti-malaria and immunosuppressive drug. Dr. Kaplan will administer it to our first responders and caregivers to study its effectiveness in treating mild COVID-19 symptoms—and preventing the disease altogether.
Based on the concept of passive immunity, this treatment involves collecting plasma from patients who have recovered from a disease—and subsequently built up antibodies to fight it—and giving it to patients who are still sick. We are ramping up a trial to study its effectiveness in treating COVID-19.
Understanding why COVID-19 affects patients differently will be vitally important in the months ahead, which is why we’re collecting tissue samples for study. While our resources are currently focused on ensuring the best care for our patients, the time to preserve those specimens is now. You can help us save those samples for later analysis with funding for resources such as a centrifuge and a -80° freezer.
We’re working to care for individuals affected by COVID-19 and to limit spread within our community. This takes a tremendous amount of resources.
Your gift makes a true impact on our fight against COVID-19. Thank you.